Search by Drug Name or NDC
NDC 00054-0650-25 Butalbital, Acetaminophen, Caffeine and Codeine Phosphate 300; 50; 40; 30 mg/1; mg/1; mg/1; mg/1 Details
Butalbital, Acetaminophen, Caffeine and Codeine Phosphate 300; 50; 40; 30 mg/1; mg/1; mg/1; mg/1
Butalbital, Acetaminophen, Caffeine and Codeine Phosphate is a ORAL CAPSULE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Hikma Pharmaceuticals USA Inc.. The primary component is ACETAMINOPHEN; BUTALBITAL; CAFFEINE; CODEINE PHOSPHATE.
MedlinePlus Drug Summary
This combination of drugs is used to relieve tension headaches. This medication is sometimes prescribed for other uses; ask your doctor or pharmacist for more information.
Related Packages: 00054-0650-25Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Acetaminophen, Butalbital, and Caffeine
Product Information
| NDC | 00054-0650 |
|---|---|
| Product ID | 0054-0650_604e214c-d5fb-4061-9a88-b582d3a45f28 |
| Associated GPIs | 65991004100113 |
| GCN Sequence Number | 071253 |
| GCN Sequence Number Description | butalbit/acetamin/caff/codeine CAPSULE 50-300-30 ORAL |
| HIC3 | H3M |
| HIC3 Description | OPIOID,NON-SALICYL.ANALGESIC,BARBITURATE,XANTHINE |
| GCN | 34988 |
| HICL Sequence Number | 001713 |
| HICL Sequence Number Description | BUTALBITAL/ACETAMINOPHEN/CAFFEINE/CODEINE PHOSPHATE |
| Brand/Generic | Generic |
| Proprietary Name | Butalbital, Acetaminophen, Caffeine and Codeine Phosphate |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Butalbital, Acetaminophen, Caffeine and Codeine Phosphate |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | CAPSULE |
| Route | ORAL |
| Active Ingredient Strength | 300; 50; 40; 30 |
| Active Ingredient Units | mg/1; mg/1; mg/1; mg/1 |
| Substance Name | ACETAMINOPHEN; BUTALBITAL; CAFFEINE; CODEINE PHOSPHATE |
| Labeler Name | Hikma Pharmaceuticals USA Inc. |
| Pharmaceutical Class | Barbiturate [EPC], Barbiturates [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Full Opioid Agonists [MoA], Methylxanthine [EPC], Opioid Agonist [EPC], Xanthines [CS] |
| DEA Schedule | CIII |
| Marketing Category | ANDA |
| Application Number | ANDA215138 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 00054-0650-25 (00054065025)
| NDC Package Code | 0054-0650-25 |
|---|---|
| Billing NDC | 00054065025 |
| Package | 100 CAPSULE in 1 BOTTLE (0054-0650-25) |
| Marketing Start Date | 2022-05-09 |
| NDC Exclude Flag | N |
| Pricing Information | |
| Price Per Unit | 5.69604 |
| Pricing Unit | EA |
| Effective Date | 2023-03-22 |
| NDC Description | BUTALBITAL-ACETAMINOPHEN-CAFFEINE-CODEINE 50-300-40-30 MG CP |
| Pharmacy Type Indicator | C/I |
| OTC | N |
| Explanation Code | 4 |
| Classification for Rate Setting | G |
| As of Date | 2024-02-21 |
This pricing file, entitled the NADAC (National Average Drug Acquisition
Cost) files, provide
state Medicaid agencies with covered outpatient drug prices by averaging
survey invoice
prices from retail community pharmacies across the United States. These
pharmacies include
independent retail community pharmacies and chain pharmacies. The prices
are updated on a
weekly and monthly basis